Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 7Menorrhagia 4Adenomyosis 2Uterine Neoplasms 1Pelvic Pain 1Patient Satisfaction 1Pain 1Myoma 1Myofibroma 1Metrorrhagia 1Hemorrhage 1

Interventions

Misoprostol 5Uterine Myomectomy 4Saline Solution 3Hysterectomy 3dienogest 2carbetocin 2Tranexamic Acid 2Tourniquets 2Lidocaine 2Hysteroscopy 2Ascorbic Acid 2remimazolam 1relugolix 1ramosetron 1Vasopressins 1Uterine Artery Embolization 1Triptorelin Pamoate 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sodium Chloride 1Sevoflurane 1Respiration, Artificial 1Remifentanil 1Propofol 1Population Groups 1Oxytocin 1Observation 1Nuclear Receptor Subfamily 4, Group A, Member 2 1Morcellation 1Methylergonovine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Myofibroma × Uterine Artery Embolization × Clear all
NCT00995878 2018-01-12

The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids.

Mayo Clinic

Phase 4 Completed
56 enrolled

Leiomyoma, Myoma, Pelvic Pain, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡